Full Press Release Details
Zymeworks to Present Trials in Progress Poster for HERIZON-GEA-01 at ESMO GI.
ZYME
Zymeworks to Present Trials in Progress Poster for HERIZON-GEA-01 at ESMO GI
Key Takeaway: Zymeworks to Present Trials in Progress Poster for HERIZON-GEA-01 at ESMO GI
Price reaction · baseline $5.88 (2022-05-17 close) · hit after-hours · clean, no other ZYME news in the window
day 0 close · peak
-12.1%
day 1
-1%
day 3
+4.3%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+23%
120-day peak, hindsight
Typical move
5.4%
average across 7 past catalysts
Cash runway
~35 mo
Minimal dilution risk
Lead asset
ZW49
Phase 1 · HER2-expressing Cancers